Victor Forge
Rheumatoid arthritis (RA) is a chronic, progressive, autoimmune, inflammatory disease that affects an estimated 0.8% of the UK population, with women being two to three times more likely to be affected than men. RA causes joint stiffness, swelling, and pain, and is associated with altered body composition, which can result in rheumatoid cachexia, or muscle wasting. This condition is characterised by a loss of skeletal muscle mass and strength, which can lead to serious complications such as heart disease and a reduced life expectancy. While the exact causes of rheumatoid cachexia are not yet known, it is believed to be related to chronic inflammation and a lack of physical activity due to joint pain and stiffness.
| Characteristics | Values |
|---|---|
| What is it called when rheumatoid arthritis causes muscle atrophy? | Rheumatoid cachexia |
| Prevalence | Affects about two-thirds of people with rheumatoid arthritis |
| Symptoms | Muscle wasting, severe weight loss, muscle loss, tired and weak muscles, elevated resting energy expenditure, physical disability, low bioavailable insulin-like growth factor, low body mass index, heart disease |
| Causes | Chronic inflammation, lack of physical activity due to joint pain and stiffness, metabolic changes, high levels of inflammatory cytokines, reduced peripheral insulin action, negative cycle of muscle loss, reduced physical function, and fat gain |
| Diagnosis | Dual-energy X-ray absorptiometry (DEXA) to measure lean body mass, imaging tests like CT scans and MRI, basic measurements like height, weight, and body mass index |
| Treatment | Exercise, specifically a combination of skeletal muscle strength training and aerobic exercise, dietary changes like a high-protein, low-carbohydrate anti-inflammatory diet, medications used to treat rheumatoid arthritis |
Explore related products
What You'll Learn
- Rheumatoid cachexia is a metabolic state caused by rheumatoid arthritis, leading to muscle wasting
- Tumour necrosis factor-alpha and interleukin-1beta are inflammatory proteins that promote muscle wasting
- Rheumatoid arthritis causes low physical activity, which leads to fat gain and muscle loss
- RA patients often present with low muscle mass and decreased strength, as measured by quantitative MRI
- There is no standard treatment for rheumatoid cachexia, but exercise is believed to be the best countermeasure
Rheumatoid cachexia is a metabolic state caused by rheumatoid arthritis, leading to muscle wasting
Rheumatoid arthritis (RA) is a chronic, progressive, autoimmune, inflammatory disease that affects the joints, causing pain, stiffness, and swelling. It is estimated to affect around 0.8% of the population in the UK, with a higher prevalence in women.
RA can lead to a metabolic state known as rheumatoid cachexia, characterised by muscle wasting and loss of functional capacity. This condition develops due to chronic inflammation and reduced physical activity associated with RA. The constant inflammation and lack of physical activity result in muscle loss and weakness, which can further contribute to fatigue and decreased quality of life.
Rheumatoid cachexia is a common complication of RA, affecting approximately two-thirds of people with uncontrolled RA. It is believed to be mediated by higher levels of inflammatory proteins called cytokines, particularly tumour necrosis factor-alpha and interleukin-1beta. These cytokines alter the balance between protein degradation and synthesis, leading to muscle wasting. Additionally, RA-related reduced peripheral insulin action may also contribute to cytokine-driven muscle loss.
The condition can be identified through imaging techniques such as quantitative MRI, CT scans, and DEXA scans, which assess body composition and muscle health. While there is no standard treatment for rheumatoid cachexia, exercise, specifically skeletal muscle strength training, and aerobic exercise, is believed to be the most effective countermeasure. Doctors may also recommend dietary changes, typically a high-protein, low-carbohydrate anti-inflammatory diet, and medications used to treat RA may also help.
Overall, rheumatoid cachexia is a serious complication of RA that leads to muscle wasting and weakness, impacting the quality of life and potentially accelerating morbidity and mortality in patients with RA. Early diagnosis and management are crucial to mitigate the effects of this condition.
Muscle Injuries: A Cause of Uncontrollable Twitching?
You may want to see also
Explore related products
Tumour necrosis factor-alpha and interleukin-1beta are inflammatory proteins that promote muscle wasting
Rheumatoid arthritis (RA) is an inflammatory disease that can lead to muscle wasting, also known as rheumatoid cachexia. This condition is characterised by a loss of muscle mass and strength, which can result in physical disability and a poor quality of life. While the exact causes of rheumatoid cachexia are not fully understood, it is believed to be associated with increased levels of inflammatory cytokines, including tumour necrosis factor-alpha (TNF-α) and interleukin-1beta (IL-1β).
TNF-α is a polypeptide cytokine that has been implicated in muscle wasting and weakness in inflammatory diseases, including RA. Studies have shown that TNF-α disrupts the differentiation process of muscle cells and promotes catabolism in mature cells. This leads to increased protein degradation and muscle wasting. Additionally, TNF-α binding to its receptor activates nuclear factor-κB (NF-κB), which further enhances protein breakdown and contributes to muscle atrophy.
IL-1β is another inflammatory cytokine that plays a crucial role in controlling inflammation and joint damage in RA. While its direct effects on skeletal muscle are not well understood, it is known to trigger inflammatory cascades that contribute to muscle wasting. IL-1β, along with TNF-α, are key players in the development of rheumatoid cachexia and the associated muscle atrophy observed in RA patients.
The presence of these inflammatory proteins, among others, contributes to the chronic inflammation and metabolic changes seen in RA, which can lead to reduced physical activity and further promote muscle wasting. Imaging techniques such as quantitative MRI can be used to assess muscle health and the extent of atrophy in RA patients, aiding in the development of preventative and therapeutic strategies.
Currently, there is no standard treatment for rheumatoid cachexia. However, exercise, specifically skeletal muscle strength training and aerobic exercise, is believed to be the best way to combat the condition. Doctors may also recommend dietary changes and medication to manage RA symptoms and improve muscle health.
Ab Workouts: Can They Cause Erectile Dysfunction?
You may want to see also
Explore related products
Rheumatoid arthritis causes low physical activity, which leads to fat gain and muscle loss
Rheumatoid arthritis (RA) is a chronic, progressive, autoimmune, inflammatory disease that affects an estimated 0.8% of the population in the UK, with a higher prevalence among women. RA causes joint stiffness, swelling, and pain, leading to low physical activity levels.
RA patients often present with low muscle mass and decreased strength, a condition known as rheumatoid cachexia or muscle wasting. This occurs when the body loses muscle mass while retaining fat mass. The constant inflammation associated with RA leads to muscle loss, and the reduced physical activity further contributes to this loss of muscle and strength. This can result in a negative cycle of muscle loss and fat gain, known as "cachectic obesity".
RA patients may experience elevated resting energy expenditure, meaning their muscles use energy even at rest, adding to the feeling of tired and achy muscles. This can also lead to serious complications such as heart disease and a reduced life expectancy.
The precise mechanism behind rheumatoid cachexia is not yet fully understood, but it is believed to be associated with higher levels of inflammatory proteins called cytokines, particularly tumor necrosis factor-alpha and interleukin-1beta. These cytokines alter the balance between protein degradation and synthesis, leading to muscle wasting. Additionally, reduced peripheral insulin action in RA patients may also contribute to cytokine-driven muscle loss.
While there is no standard treatment for rheumatoid cachexia, exercise is believed to be the most effective countermeasure. Doctors often recommend a combination of skeletal muscle strength training and aerobic exercise tailored to the patient's health and safety needs. Dietary changes, such as adding fish oil and following a high-protein, low-carbohydrate anti-inflammatory diet, can also help manage the condition.
Chlorthalidone Side Effects: Muscle Weakness Explained
You may want to see also
Explore related products
RA patients often present with low muscle mass and decreased strength, as measured by quantitative MRI
Rheumatoid arthritis (RA) is a chronic, progressive, autoimmune, inflammatory disease with a prevalence of 0.8% in the UK. It is characterised by joint stiffness, swelling, and pain. RA patients often experience muscle deterioration and loss of muscle mass and strength, also known as rheumatoid cachexia or muscle wasting. This condition occurs in about two-thirds of people with RA and is believed to be caused by chronic inflammation and lack of physical activity due to joint pain and stiffness.
The study by Farrow et al. (2021) used quantitative MRI to assess muscle deterioration in RA patients. They scanned the dominant thighs of 39 RA patients at different disease stages and compared them to 13 healthy controls. The results showed reduced fractional anisotropy in the quadriceps of RA patients, which could be due to the atrophy of type II muscle fibres caused by the denervation of motor units. Handgrip strength and knee extension and flexion were also found to be lower in RA patients compared to healthy controls.
The use of quantitative MRI to assess muscle health in RA patients can aid in the development of preventative and therapeutic strategies. It can help improve the understanding of muscle involvement in RA and guide the creation of exercise interventions to restore muscle quality. Additionally, it can assist in monitoring the effectiveness of treatments such as exercise, medication, and supplements.
Topiramate and Muscle Loss: What's the Link?
You may want to see also
Explore related products
There is no standard treatment for rheumatoid cachexia, but exercise is believed to be the best countermeasure
Rheumatoid arthritis (RA) is an inflammatory disease that can lead to a metabolic state called rheumatoid cachexia, or muscle wasting. This condition occurs when the body loses muscle mass but retains fat mass. Rheumatoid cachexia is common in people with RA, affecting about two-thirds of patients. While there is no standard treatment for rheumatoid cachexia, exercise is believed to be the best countermeasure.
Exercise can play a crucial role in halting or reversing muscle wasting associated with rheumatoid cachexia. A combination of skeletal muscle strength training and aerobic exercise is recommended. Doctors can create personalised workout plans that take into account the individual's overall health, disease status, and safety concerns. Additionally, resistance exercises have been shown to reduce skeletal muscle cachexia and improve muscle function in people with RA.
The inclusion of specific dietary supplements can also aid in treating rheumatoid cachexia. Studies have suggested that adding fish oil to one's diet can improve weight and muscle strength while reducing fatigue. Doctors often recommend a high-protein, low-carbohydrate anti-inflammatory diet for patients with rheumatoid cachexia. However, it is important to note that merely eating more is not a solution, as the affected muscles may not absorb nutrition properly.
While there are no reliable tests to diagnose rheumatoid cachexia, doctors employ various methods to identify the condition. These include measuring body mass index (BMI), assessing levels of malnutrition, and using imaging techniques such as MRI scans and CT scans to identify muscle wasting. Bioimpedance analysis (BIA) is another tool that helps measure the body's fat-free mass.
Medications used to treat RA may also help improve muscle mass in patients with rheumatoid cachexia. These medications include biological medications, a relatively new treatment option for RA, and drugs like Humira, which is a tumour necrosis factor (TNF) inhibitor that suppresses the immune system.
Food Allergies: The Surprising Link to Muscle Soreness
You may want to see also
Frequently asked questions
Rheumatoid cachexia is a metabolic state that causes muscle wasting and is common in people with rheumatoid arthritis (RA). It is characterised by muscle weakness and a loss of functional capacity. It is believed to accelerate morbidity and mortality in rheumatoid arthritis.
Rheumatoid cachexia is caused by chronic inflammation and a lack of physical activity due to RA. Tumour necrosis factor-alpha and interleukin-1beta are believed to alter the balance between protein degradation and protein synthesis, leading to muscle wasting.
There is no standard treatment for rheumatoid cachexia. However, exercise is believed to be the most effective countermeasure. Doctors recommend a combination of skeletal muscle strength training and aerobic exercise, tailored to the patient's health, disease status, and safety concerns. Dietary changes, such as adding fish oil and following a high-protein, low-carbohydrate anti-inflammatory diet, can also help.
